ACR Alpine Capital Research’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $545M | Sell |
2,146,488
-10,896
| -0.5% | -$2.54M | 7.74% | 2 |
|
|
2026
Q1 | $527M | Sell |
2,157,384
-79,664
| -4% | -$18.6M | 7.87% | 3 |
|
|
2025
Q4 | $463M | Buy |
2,237,048
+4,972
| +0.2% | +$983K | 7.22% | 3 |
|
|
2025
Q3 | $414M | Buy |
2,232,076
+3,134
| +0.1% | +$537K | 7.07% | 4 |
|
|
2025
Q2 | $340M | Buy |
2,228,942
+2,383
| +0.1% | +$366K | 6.1% | 9 |
|
|
2025
Q1 | $369M | Buy |
2,226,559
+386,322
| +21% | +$60.4M | 7.73% | 3 |
|
|
2024
Q4 | $266M | Buy |
1,840,237
+655,818
| +55% | +$102M | 5.77% | 8 |
|
|
2024
Q3 | $192M | Buy |
1,184,419
+6,045
| +0.5% | +$963K | 5.67% | 10 |
|
|
2024
Q2 | $172M | Buy |
1,178,374
+55,402
| +5% | +$8.24M | 5.32% | 10 |
|
|
2024
Q1 | $178M | Buy |
1,122,972
+111,837
| +11% | +$17.8M | 5.39% | 11 |
|
|
2023
Q4 | $158M | Buy |
1,011,135
+25,646
| +3% | +$3.93M | 5.35% | 10 |
|
|
2023
Q3 | $153M | Buy |
985,489
+30,971
| +3% | +$5.11M | 5.97% | 13 |
|
|
2023
Q2 | $158M | Buy |
954,518
+6,793
| +0.7% | +$1.1M | 5.96% | 11 |
|
|
2023
Q1 | $147M | Buy |
947,725
+25,695
| +3% | +$4.15M | 5.98% | 11 |
|
|
2022
Q4 | $163M | Sell |
922,030
-18,188
| -2% | -$3.14M | 7.31% | 7 |
|
|
2022
Q3 | $154M | Buy |
940,218
+24,374
| +3% | +$4.12M | 7.61% | 5 |
|
|
2022
Q2 | $163M | Buy |
915,844
+4,129
| +0.5% | +$736K | 7.38% | 7 |
|
|
2022
Q1 | $162M | Buy |
911,715
+26,299
| +3% | +$4.47M | 8.02% | 8 |
|
|
2021
Q4 | $151M | Buy |
885,416
+165,925
| +23% | +$27.2M | 8.14% | 8 |
|
|
2021
Q3 | $116M | Buy |
719,491
+15,040
| +2% | +$2.57M | 6.59% | 10 |
|
|
2021
Q2 | $116M | Sell |
704,451
-391
| -0.1% | -$64.7K | 6.37% | 10 |
|
|
2021
Q1 | $116M | Buy |
704,842
+8,790
| +1% | +$1.42M | 6.26% | 10 |
|
|
2020
Q4 | $110M | Buy |
696,052
+25,681
| +4% | +$3.79M | 6.3% | 10 |
|
|
2020
Q3 | $99.8M | Sell |
670,371
-37,648
| -5% | -$5.57M | 7.1% | 6 |
|
|
2020
Q2 | $99.6M | Sell |
708,019
-56,574
| -7% | -$8.24M | 6.61% | 8 |
|
|
2020
Q1 | $100M | Sell |
764,593
-13,878
| -2% | -$1.97M | 6.66% | 6 |
|
|
2019
Q4 | $114M | Sell |
778,471
-27,681
| -3% | -$3.75M | 5.91% | 6 |
|
|
2019
Q3 | $104M | Buy |
806,152
+22,641
| +3% | +$2.98M | 5.26% | 7 |
|
|
2019
Q2 | $109M | Sell |
783,511
-38,603
| -5% | -$5.34M | 5.77% | 8 |
|
|
2019
Q1 | $115M | Sell |
822,114
-15,837
| -2% | -$2.12M | 5.92% | 7 |
|
|
2018
Q4 | $108M | Sell |
837,951
-8,299
| -1% | -$1.16M | 5.53% | 6 |
|
|
2018
Q3 | $117M | Buy |
846,250
+2,821
| +0.3% | +$375K | 6.2% | 7 |
|
|
2018
Q2 | $102M | Buy |
843,429
+60,867
| +8% | +$7.59M | 5.5% | 8 |
|
|
2018
Q1 | $100M | Sell |
782,562
-31,069
| -4% | -$4.2M | 5.45% | 8 |
|
|
2017
Q4 | $114M | Sell |
813,631
-20,622
| -2% | -$2.87M | 6.03% | 7 |
|
|
2017
Q3 | $108M | Sell |
834,253
-26,919
| -3% | -$3.57M | 5.86% | 6 |
|
|
2017
Q2 | $114M | Sell |
861,172
-49,261
| -5% | -$6.28M | 9.79% | 3 |
|
|
2017
Q1 | $113M | Buy |
910,433
+1,916
| +0.2% | +$229K | 9.73% | 4 |
|
|
2016
Q4 | $105M | Sell |
908,517
-92,998
| -9% | -$10.7M | 8.45% | 3 |
|
|
2016
Q3 | $118M | Buy |
1,001,515
+12,869
| +1% | +$1.56M | 8.19% | 5 |
|
|
2016
Q2 | $120M | Sell |
988,646
-20,862
| -2% | -$2.37M | 9.18% | 3 |
|
|
2016
Q1 | $109M | Buy |
1,009,508
+21,139
| +2% | +$2.19M | 8.7% | 3 |
|
|
2015
Q4 | $102M | Buy |
988,369
+34,073
| +4% | +$3.43M | 10.16% | 4 |
|
|
2015
Q3 | $89.1M | Buy |
954,296
+51,643
| +6% | +$5M | 9.76% | 4 |
|
|
2015
Q2 | $88M | Buy |
902,653
+61,900
| +7% | +$6.2M | 10.98% | 4 |
|
|
2015
Q1 | $84.6M | Buy |
840,753
+118,685
| +16% | +$12.1M | 10.28% | 3 |
|
|
2014
Q4 | $75.5M | Buy |
722,068
+52,466
| +8% | +$5.53M | 9.92% | 3 |
|
|
2014
Q3 | $71.4M | Buy |
669,602
+39,108
| +6% | +$4.06M | 10.65% | 3 |
|
|
2014
Q2 | $66M | Buy |
630,494
+15,011
| +2% | +$1.52M | 10.09% | 4 |
|
|
2014
Q1 | $60.5M | Buy |
615,483
+123,299
| +25% | +$11.4M | 10.07% | 3 |
|
|
2013
Q4 | $45.1M | Buy |
492,184
+31,812
| +7% | +$2.93M | 9.09% | 7 |
|
|
2013
Q3 | $39.9M | Buy |
460,372
+38,610
| +9% | +$3.46M | 9.29% | 5 |
|
|
2013
Q2 | $36.2M | Buy |
+421,762
| New | +$35.8M | 8.23% | 3 |
|
Other funds holding JNJ
ACR Alpine Capital Research's JNJ Position: Q2 2026 in Review
ACR Alpine Capital Research reduced its Johnson & Johnson (JNJ) stake by 0.51% in Q2 2026, selling an estimated $2.54M and leaving 2,146,488 shares worth $545M. The position accounts for 7.74% of the portfolio, ranked #2.
ACR Alpine Capital Research first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- ACR Alpine Capital Research held 2,146,488 shares of Johnson & Johnson worth $545M as of Q2 2026.
- ACR Alpine Capital Research sold 10,896 Johnson & Johnson shares in Q2 2026, an estimated $2.54M.
- Johnson & Johnson made up 7.74% of ACR Alpine Capital Research's portfolio in Q2 2026, its #2 holding.
- ACR Alpine Capital Research first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
- 4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on ACR Alpine Capital Research's 13F filing for Q2 2026, filed 29 Jul 2026.